 BOULDER, Colo., July 26, 2021 GLOBE NEWSWIRE -- Viridian Therapeutics, Inc. Nasdaq: VRDN, a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by todays therapies, today announced the appointment of Kristian Humer as its new Chief Financial Officer and Chief Business Officer. 